HRT Financial’s ACM Research ACMR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.09M Buy
129,328
+30,988
+32% +$1.65M 0.01% 985
2025
Q4
$3.88M Buy
98,340
+61,961
+170% +$2.31M 0.01% 902
2025
Q3
$1.42M Sell
36,379
-169,329
-82% -$5.03M 0.01% 1342
2025
Q2
$5.33M Buy
+205,708
New +$4.63M 0.02% 506
2023
Q4
Sell
-56,095
Closed -$1.01M 2234
2023
Q3
$1.01M Buy
56,095
+21,042
+60% +$313K 0.01% 967
2023
Q2
$458K Buy
35,053
+11,631
+50% +$123K ﹤0.01% 1401
2023
Q1
$274K Sell
23,422
-4,551
-16% -$52.6K ﹤0.01% 1763
2022
Q4
$215K Buy
+27,973
New +$237K ﹤0.01% 1907
2022
Q1
Sell
-17,397
Closed -$494K 3006
2021
Q4
$494K Sell
17,397
-48,234
-73% -$1.52M ﹤0.01% 1865
2021
Q3
$2.41M Buy
+65,631
New +$2.01M 0.01% 624
2021
Q2
Sell
-85,905
Closed -$2.31M 2765
2021
Q1
$2.31M Buy
+85,905
New +$2.84M 0.02% 546
2020
Q4
Sell
-18,183
Closed -$418K 1779
2020
Q3
$418K Buy
18,183
+7,182
+65% +$204K 0.01% 965
2020
Q2
$228K Buy
+11,001
New +$181K 0.01% 1099

Other funds holding ACMR

HRT Financial's ACMR Position: Q1 2026 in Review

HRT Financial increased its ACM Research (ACMR) stake by 32% in Q1 2026, buying an estimated $1.65M and bringing the position to 129,328 shares worth $5.09M. The position accounts for 0.01% of the portfolio, ranked #985.

HRT Financial first reported a position in ACMR in Q2 2020 and has held it in 13 quarters since. The position peaked at $5.33M in Q2 2025. 300 funds tracked by Wall St. Rank hold ACMR as of Q1 2026.

  • HRT Financial held 129,328 shares of ACM Research worth $5.09M as of Q1 2026.
  • HRT Financial bought 30,988 ACM Research shares in Q1 2026, an estimated $1.65M.
  • ACM Research made up 0.01% of HRT Financial's portfolio in Q1 2026, its #985 holding.
  • HRT Financial first reported a position in ACM Research in Q2 2020 and has held it in 13 quarters since.
  • HRT Financial's ACM Research position peaked at $5.33M in Q2 2025.
  • 300 funds tracked by Wall St. Rank held ACM Research as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.